Treating Myomatous Erythrocytosis Syndrome With Uterine Artery Embolization
| Autor: | Brian Gordon, Tucker Fischbeck, Stuart Schroff, Russell M. Salamo |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Secondary Polycythemia
medicine.medical_specialty medicine.medical_treatment Polycythemia Hematocrit 03 medical and health sciences 0302 clinical medicine Uterine artery embolization Humans Medicine 030212 general & internal medicine 030219 obstetrics & reproductive medicine Uterine leiomyoma Hysterectomy Leiomyoma medicine.diagnostic_test business.industry Obstetrics and Gynecology Interventional radiology Syndrome Middle Aged Uterine Artery Embolization medicine.disease Thrombosis Surgery Treatment Outcome Uterine Neoplasms Female business |
| Zdroj: | Obstetrics & Gynecology. 133:1274-1277 |
| ISSN: | 0029-7844 |
| DOI: | 10.1097/aog.0000000000003289 |
| Popis: | Background Myomatous erythrocytosis syndrome, a form of secondary polycythemia associated with uterine leiomyomas, increases the risk of thrombosis and traditionally has been treated with hysterectomy. Case The patient is a 68-year-old woman with 7-year history of polycythemia initially thought to be secondary to a gastrointestinal stromal tumor that persisted after resection. A subsequent search for an alternative etiology led to the discovery of an 11.2-cm submucosal leiomyoma and likelihood of myomatous erythrocytosis syndrome. The patient declined surgical management and continued to undergo recurrent phlebotomy to maintain a hematocrit of less than 45% until consultation with an interventional radiology specialist. She underwent uterine artery embolization in July 2017, and her hematocrit has remained within normal limits through 17 months of follow-up. Conclusion Uterine artery embolization is an effective alternative treatment modality for myomatous erythrocytosis syndrome. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|